Renuvion Safely and Effectively Treats Lax Skin in Trial
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
Facial plastic surgeon Konstantin Vasyukevich, MD, shares how personalized mini-lifts and targeted injectables are meeting patient demand for natural results with minimal downtime.
Podcast episodes examine a global accreditation effort for non-surgical aesthetics and the steps providers can take to improve patient safety and operational standards.
Suneva Medical, Inc. announces that its nonsurgical thread life, Silhouette InstaLift®, has won the Best Thread Lift Treatment title in NewBeauty’s 2022 Beauty Awards.
Read MoreResearchers used advanced 3D facial analysis to improve surgical decisions for gender-affirming facial surgery.
Read MorePDO Max, Inc., a provider of U.S. FDA-cleared polydioxanone (PDO) threads-in-cannula medical devices for non-surgical facial tissue repositioning, announces that its PDO device continues to comply with the Medical Device Single Audit Program, or MDSAP, certification.
Read MoreA report published by Global Industry Analysts expects the global aesthetic services market to hit $23.3 billion by 2026.
Read MoreThanks to a recent viral TikTok video, eyelid lift surgeries may be the next rising trend in plastic surgery.
Read More